Israel, A.; Shenhar, Y.; Green, I.; Merzon, E.; Golan-Cohen, A.; Schäffer, A.A.; Ruppin, E.; Vinker, S.; Magen, E.
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines 2022, 10, 64.
https://doi.org/10.3390/vaccines10010064
AMA Style
Israel A, Shenhar Y, Green I, Merzon E, Golan-Cohen A, Schäffer AA, Ruppin E, Vinker S, Magen E.
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines. 2022; 10(1):64.
https://doi.org/10.3390/vaccines10010064
Chicago/Turabian Style
Israel, Ariel, Yotam Shenhar, Ilan Green, Eugene Merzon, Avivit Golan-Cohen, Alejandro A. Schäffer, Eytan Ruppin, Shlomo Vinker, and Eli Magen.
2022. "Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection" Vaccines 10, no. 1: 64.
https://doi.org/10.3390/vaccines10010064
APA Style
Israel, A., Shenhar, Y., Green, I., Merzon, E., Golan-Cohen, A., Schäffer, A. A., Ruppin, E., Vinker, S., & Magen, E.
(2022). Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection. Vaccines, 10(1), 64.
https://doi.org/10.3390/vaccines10010064